| pubmed-article:9738741 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9738741 | lifeskim:mentions | umls-concept:C0008972 | lld:lifeskim |
| pubmed-article:9738741 | lifeskim:mentions | umls-concept:C1335703 | lld:lifeskim |
| pubmed-article:9738741 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:9738741 | lifeskim:mentions | umls-concept:C1955835 | lld:lifeskim |
| pubmed-article:9738741 | lifeskim:mentions | umls-concept:C1285530 | lld:lifeskim |
| pubmed-article:9738741 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:9738741 | pubmed:dateCreated | 1998-10-8 | lld:pubmed |
| pubmed-article:9738741 | pubmed:abstractText | Laser therapy is becoming a more precise, minimally invasive alternative for tumor ablation. Recent reports confirm successful palliation of pain and functional disabilities in patients with advanced deep carcinoma of the head and neck using interstitial laser phototherapy (ILT). STUDY DESIGN, PATIENTS, AND METHODS: The current study describes an ongoing Phase II trial of neodymium/yttrium-aluminum-garnet (Nd:YAG) laser therapy for palliation of advanced head and neck cancer. A total of 40 advanced cancer patients have been entered into this protocol (25 men and 15 women). | lld:pubmed |
| pubmed-article:9738741 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9738741 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9738741 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9738741 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9738741 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9738741 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9738741 | pubmed:issn | 0023-852X | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:CalcaterraT... | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:WardP HPH | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:SoudantJJ | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:SaxtonR ERE | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:CastroD JDJ | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:PatonK CKC | lld:pubmed |
| pubmed-article:9738741 | pubmed:author | pubmed-author:BlackwellK... | lld:pubmed |
| pubmed-article:9738741 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9738741 | pubmed:volume | 108 | lld:pubmed |
| pubmed-article:9738741 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9738741 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9738741 | pubmed:pagination | 1277-83 | lld:pubmed |
| pubmed-article:9738741 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:meshHeading | pubmed-meshheading:9738741-... | lld:pubmed |
| pubmed-article:9738741 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9738741 | pubmed:articleTitle | Palliative laser therapy for recurrent head and neck cancer: a Phase II clinical study. | lld:pubmed |
| pubmed-article:9738741 | pubmed:affiliation | Division of Head and Neck Surgery, University of California, Los Angeles, School of Medicine, 90095-1794, USA. | lld:pubmed |
| pubmed-article:9738741 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9738741 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9738741 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9738741 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:9738741 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
